COMBS ANDREW P has a total of 13 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are APOGLYX AB, KALYPSYS INC and BIAL PORTELA & Cª S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Combs Andrew P | 13 |
#2 | Sparks Richard B | 8 |
#3 | Yue Eddy W | 6 |
#4 | Glass Brian M | 5 |
#5 | Zhu Wenyu | 3 |
#6 | Li Yun-Long | 3 |
#7 | Yue Eddy Wai | 3 |
#8 | Mei Song | 2 |
#9 | Yue Tai-Yuen | 1 |
#10 | Takvorian Amy | 1 |
Publication | Filing date | Title |
---|---|---|
US2014057912A1 | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors | |
US2011190319A1 | Substituted heteroaryl fused derivatives as PI3K inhibitors | |
US2007203140A1 | N-hydroxyguanidines as modulators of indoleamine 2,3-dioxygenase | |
US2007185165A1 | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |